13th European Headache Federation Congress 2019 - Abstracts

Overview of attention for article published in The Journal of Headache and Pain, December 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review

Article in Frontiers in Neurology (March 2024)

Anxiety and Depressive Symptoms and Disorders in Children and Adolescents With Migraine

Article in JAMA Pediatrics (December 2022)

Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)

Article in Clinical Drug Investigation (January 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.